A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.

CONCLUSION: Naloxegol was generally safe and well tolerated in this 12-week extension study in patients with noncancer pain and OIC.
PMID: 28059433 [PubMed - in process]

Source: Journal of Opioid Management - January 10, 2017 Category: Addiction Tags: J Opioid Manag Source Type: research